Yazdani Shiraz, Abdi Salahadin
Department of Pain Medicine, The University of Texas, MD Anderson Cancer Center, 1400 Holcombe Blvd, Unit 409, Houston, TX, 77030, USA.
Can J Anaesth. 2014 Aug;61(8):745-53. doi: 10.1007/s12630-014-0170-5. Epub 2014 May 6.
As the number of cancer survivors continues to increase due to advances in medicine, many cancer survivors remain on their same pain management regimen long after their cancer treatment has been completed. Thus, the purpose of this review is to encourage awareness of the challenges and opportunities of pain management in cancer survivorship. It is our expectation that these patients will be referred to pain medicine specialists so their pain management can be optimized during the period of survivorship and ultimately improve their quality of life.
Cancer and its treatment can cause significant pain which requires multidrug therapy, including strong analgesics such as opioids. Optimal pain management has been shown to improve the quality of life of cancer patients, and that is also true for cancer survivors. Nevertheless, the appropriate use of pain medications, especially opioids, must be re-evaluated and adjusted during treatment as the patient transitions into survivorship care and thereafter. This may otherwise result in unnecessary opioid use or may even lead to abuse. Fortunately, as cancer treatment is completed and the survivorship period begins, pain improves gradually and the need for pain medication should decrease. Unfortunately, some patients continue to take their potent analgesics during the period of survivorship although it may not be necessary. It is a challenge for pain practitioners who do not see these patients early in their disease or in the recovery period. Nevertheless, this challenge presents an opportunity for pain management providers to educate oncologists to refer cancer survivors to pain centres early during the period of their survivorship. Cancer survivors could then receive optimal care and maintain a better quality of life without having to take unnecessary pain medications.
It is clear that there is a need to improve pain management in cancer patients, particularly in cancer survivors. Pain physicians should play a critical role as part of a multidisciplinary team that cares not only for cancer patients but also for cancer survivors. Optimizing pain management during the cancer survivorship period results in a better quality of life.
由于医学进步,癌症幸存者的数量持续增加,许多癌症幸存者在完成癌症治疗后很长时间仍维持原有的疼痛管理方案。因此,本综述的目的是提高对癌症幸存者疼痛管理挑战与机遇的认识。我们期望这些患者能被转介至疼痛医学专家处,以便在生存期间优化其疼痛管理,最终提高生活质量。
癌症及其治疗可导致严重疼痛,这需要多药联合治疗,包括使用阿片类等强效镇痛药。最佳疼痛管理已被证明可改善癌症患者的生活质量,对癌症幸存者也是如此。然而,随着患者过渡到生存护理阶段及之后,在治疗过程中必须重新评估并调整疼痛药物,尤其是阿片类药物的合理使用。否则可能导致不必要的阿片类药物使用,甚至可能导致滥用。幸运的是,随着癌症治疗完成且生存阶段开始,疼痛会逐渐改善,对疼痛药物的需求应会减少。不幸的是,一些患者在生存期间仍继续服用强效镇痛药,尽管可能并无必要。对于在疾病早期或康复期未诊治这些患者的疼痛治疗医生而言,这是一项挑战。然而,这一挑战为疼痛管理提供者提供了一个机会,可教育肿瘤学家在癌症幸存者生存早期将其转介至疼痛中心。这样癌症幸存者就能接受最佳护理,维持更好的生活质量,而无需服用不必要的止痛药物。
显然,有必要改善癌症患者尤其是癌症幸存者的疼痛管理。疼痛医生应作为多学科团队的关键成员发挥作用,该团队不仅要照顾癌症患者,也要照顾癌症幸存者。在癌症生存期间优化疼痛管理可带来更好的生活质量。